| HOME >> BIOLOGY >> TECHNOLOGY |
Earnings from
discontinued
operations,
net of tax 1.6 (1.6)(l) - 28.7 (28.7)(l) -
Net earnings $ 166.5 $(27.8) $ 138.7 $124.6 $(6.2) $ 118.4
Basic earnings
per share
Continuing
operations $2.64 (0.42) $2.22 $1.53 0.36 $1.89
Discontinued
operations 0.03 (0.03) - 0.46 (0.46) -
Basic earnings
per share $2.67 $(0.45) $2.22 $1.99$(0.10) $1.89
Diluted earnings
per share
Continuing
operations $2.58 (0.41) $2.17 $1.50 0.35 $1.85
Discontinued
operations 0.03 (0.03) - 0.45 (0.45) -
Diluted earnings
per share $2.61 $(0.44) $2.17 $1.95$(0.10) $1.85
Weighted average
number of shares
outstanding
(in thousands):
Basic 62,379 62,379 62,636 62,636
Dilutive 63,908 63,908 64,003 64,003
* See accompanying Non-GAAP Financial Measures section for description of
Non-GAAP adjustments.
Non-GAAP Financial Measures
Certain disclosures prepared in accordance with U.S. Generally Accepted
Accounting Principles (GAAP) included in this release are accompanied by
disclosures that are not prepared in conformity with GAAP. Management has
determined that these disclosures provide investors a more complete
understanding of the company's results, as these income and expense items
are not expected to recur in subsequent periods, or in the case of
restructuring and supply chain initiatives, could vary significantly based
upon the project or initiative. Given the significance and unusual nature
of these income or expense items relative to the operating results for the
periods present
'/>"/>
| SOURCE Beckman Coulter, Inc. Copyright©2007 PR Newswire. All rights reserved |